| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.85e-11 | 25 | 166 | 8 | GO:0017056 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 1.87e-09 | 27 | 166 | 7 | GO:0008139 | |
| GeneOntologyMolecularFunction | signal sequence binding | 9.05e-09 | 51 | 166 | 8 | GO:0005048 | |
| GeneOntologyMolecularFunction | chromatin binding | MKRN4P FOXO3 SP3 EP400 CENPB MAZ NUP98 NUP62 ISL1 CREBBP RING1 TRIM33 PARP1 PRDM8 SALL1 GLI2 KMT2A MLLT6 TAF5 NUP153 | 3.54e-06 | 739 | 166 | 20 | GO:0003682 |
| GeneOntologyMolecularFunction | C4-dicarboxylate transmembrane transporter activity | 5.85e-06 | 15 | 166 | 4 | GO:0015556 | |
| GeneOntologyMolecularFunction | L-aspartate transmembrane transporter activity | 6.49e-05 | 10 | 166 | 3 | GO:0015183 | |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 1.22e-04 | 31 | 166 | 4 | GO:0005310 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXO3 FOXO3B SP1 SP3 ARGFX NACC1 MAZ ZBTB22 DACH1 ZBTB12 ISL1 ZNF524 ZNF71 FOXP4 ZNF23 OTX1 SALL1 ZNF852 GLI2 NKX1-1 TBXT NR3C2 FOXK1 | 2.61e-04 | 1244 | 166 | 23 | GO:0000978 |
| GeneOntologyMolecularFunction | peptide binding | TPP2 NUP98 NUP214 NUP58 POM121C TOMM70 POM121 POM121B NUP153 MAPK8IP2 | 3.39e-04 | 318 | 166 | 10 | GO:0042277 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FOXO3 FOXO3B SP1 SP3 ARGFX NACC1 MAZ ZBTB22 DACH1 ZBTB12 ISL1 ZNF524 ZNF71 FOXP4 ZNF23 OTX1 SALL1 ZNF852 GLI2 NKX1-1 TBXT NR3C2 FOXK1 | 3.54e-04 | 1271 | 166 | 23 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXO3 FOXO3B SP1 SP3 ARGFX NACC1 MAZ ZBTB22 DACH1 ZBTB12 ISL1 ZNF524 HMX2 CREBBP ZNF71 FOXP4 ZNF23 OTX1 SALL1 ZNF852 GLI2 NKX1-1 TBXT NR3C2 FOXK1 | 4.36e-04 | 1459 | 166 | 25 | GO:0000977 |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 4.83e-04 | 44 | 166 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 5.80e-04 | 20 | 166 | 3 | GO:0015172 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 6.44e-04 | 83 | 166 | 5 | GO:1990841 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 7.39e-04 | 129 | 166 | 6 | GO:0035591 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | FOXO3 FOXO3B SP1 SP3 ARGFX NACC1 MAZ ZBTB22 DACH1 ZBTB12 ISL1 HMX2 ZNF71 FOXP4 ZNF23 OTX1 SALL1 ZNF852 GLI2 NKX1-1 TBXT NR3C2 FOXK1 | 1.48e-03 | 1412 | 166 | 23 | GO:0000981 |
| GeneOntologyBiologicalProcess | nuclear pore organization | 4.57e-09 | 18 | 168 | 6 | GO:0006999 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | NUP98 WWTR1 NUP62 NUP214 NUP58 POM121C CREBBP PARP1 POM121 LMNA TBRG1 DCP1B POM121B NUP153 | 1.68e-06 | 362 | 168 | 14 | GO:0034504 |
| GeneOntologyBiologicalProcess | mRNA transport | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 2.99e-06 | 145 | 168 | 9 | GO:0051028 |
| GeneOntologyBiologicalProcess | L-aspartate import across plasma membrane | 1.04e-05 | 6 | 168 | 3 | GO:0140009 | |
| GeneOntologyBiologicalProcess | nucleus organization | SEH1L NUP98 POM121C CHMP2A POM121 LMNA NECTIN2 POM121B NUP153 | 1.09e-05 | 170 | 168 | 9 | GO:0006997 |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 1.36e-05 | 96 | 168 | 7 | GO:0006405 | |
| GeneOntologyBiologicalProcess | RNA transport | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 1.38e-05 | 175 | 168 | 9 | GO:0050658 |
| GeneOntologyBiologicalProcess | nucleic acid transport | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 1.38e-05 | 175 | 168 | 9 | GO:0050657 |
| GeneOntologyBiologicalProcess | establishment of RNA localization | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 1.58e-05 | 178 | 168 | 9 | GO:0051236 |
| GeneOntologyBiologicalProcess | protein import into nucleus | 3.25e-05 | 195 | 168 | 9 | GO:0006606 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B SLC25A23 NUP153 | 3.89e-05 | 249 | 168 | 10 | GO:0015931 |
| GeneOntologyBiologicalProcess | import into nucleus | 4.12e-05 | 201 | 168 | 9 | GO:0051170 | |
| GeneOntologyBiologicalProcess | RNA localization | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 7.46e-05 | 217 | 168 | 9 | GO:0006403 |
| GeneOntologyBiologicalProcess | L-aspartate transmembrane transport | 8.35e-05 | 11 | 168 | 3 | GO:0070778 | |
| GeneOntologyBiologicalProcess | C4-dicarboxylate transport | 8.60e-05 | 29 | 168 | 4 | GO:0015740 | |
| GeneOntologyBiologicalProcess | notochord morphogenesis | 1.11e-04 | 12 | 168 | 3 | GO:0048570 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 1.21e-04 | 343 | 168 | 11 | GO:0090596 | |
| GeneOntologyBiologicalProcess | regulation of intracellular estrogen receptor signaling pathway | 2.04e-04 | 36 | 168 | 4 | GO:0033146 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 2.75e-04 | 204 | 168 | 8 | GO:0048592 | |
| GeneOntologyBiologicalProcess | nuclear transport | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C RGS14 POM121 LMNA POM121B NUP153 | 2.81e-04 | 378 | 168 | 11 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C RGS14 POM121 LMNA POM121B NUP153 | 2.81e-04 | 378 | 168 | 11 | GO:0006913 |
| GeneOntologyCellularComponent | nuclear pore | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C CHMP2A POM121 POM121B NUP153 | 9.86e-09 | 101 | 170 | 10 | GO:0005643 |
| Domain | DUF4599 | 3.70e-10 | 12 | 164 | 6 | PF15371 | |
| Domain | DUF4599 | 3.70e-10 | 12 | 164 | 6 | IPR027970 | |
| Domain | NA_DICARBOXYL_SYMP_1 | 2.27e-05 | 7 | 164 | 3 | PS00713 | |
| Domain | NA_DICARBOXYL_SYMP_2 | 2.27e-05 | 7 | 164 | 3 | PS00714 | |
| Domain | SDF | 2.27e-05 | 7 | 164 | 3 | PF00375 | |
| Domain | - | 2.27e-05 | 7 | 164 | 3 | 1.10.3860.10 | |
| Domain | Na-dicarboxylate_symporter | 2.27e-05 | 7 | 164 | 3 | IPR001991 | |
| Domain | Na-dicarboxylate_symporter_CS | 2.27e-05 | 7 | 164 | 3 | IPR018107 | |
| Domain | Ago_hook | 2.29e-04 | 3 | 164 | 2 | PF10427 | |
| Domain | TNRC6_PABC-bd | 2.29e-04 | 3 | 164 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 2.29e-04 | 3 | 164 | 2 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 2.29e-04 | 3 | 164 | 2 | PF16608 | |
| Domain | VWF_type-D | 3.42e-04 | 16 | 164 | 3 | IPR001846 | |
| Domain | VWFD | 3.42e-04 | 16 | 164 | 3 | PS51233 | |
| Domain | AT_hook | 3.42e-04 | 16 | 164 | 3 | PF02178 | |
| Domain | VWD | 3.42e-04 | 16 | 164 | 3 | SM00216 | |
| Domain | VWD | 3.42e-04 | 16 | 164 | 3 | PF00094 | |
| Domain | TSC-22_Dip_Bun | 4.55e-04 | 4 | 164 | 2 | IPR000580 | |
| Domain | Ion_trans_N | 4.55e-04 | 4 | 164 | 2 | IPR013621 | |
| Domain | TSC-22_Dip_Bun | 4.55e-04 | 4 | 164 | 2 | PD007152 | |
| Domain | Ion_trans_N | 4.55e-04 | 4 | 164 | 2 | PF08412 | |
| Domain | TSC22 | 4.55e-04 | 4 | 164 | 2 | PF01166 | |
| Domain | TSC22 | 4.55e-04 | 4 | 164 | 2 | PS01289 | |
| Domain | ZINC_FINGER_C2H2_2 | SP1 SP3 MAZ ZBTB22 ZBTB12 ZNF524 ZNF71 FOXP4 PRDM8 ZNF23 SALL1 ZNF608 ZNF852 ZNF592 GLI2 ZC3H7B ZNF839 | 4.81e-04 | 775 | 164 | 17 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | SP1 SP3 MAZ ZBTB22 ZBTB12 ZNF524 ZNF71 FOXP4 PRDM8 ZNF23 SALL1 ZNF608 ZNF852 ZNF592 GLI2 ZC3H7B ZNF839 | 4.95e-04 | 777 | 164 | 17 | PS00028 |
| Domain | Znf_C2H2-like | SP1 SP3 MAZ ZBTB22 ZBTB12 ZNF524 ZNF71 FOXP4 PRDM8 ZNF23 SALL1 ZNF608 ZNF852 ZNF592 GLI2 ZC3H7B ZNF839 | 6.50e-04 | 796 | 164 | 17 | IPR015880 |
| Domain | Znf_C2H2 | SP1 SP3 MAZ ZBTB22 ZBTB12 ZNF524 ZNF71 FOXP4 PRDM8 ZNF23 SALL1 ZNF608 ZNF852 ZNF592 GLI2 ZC3H7B ZNF839 | 7.36e-04 | 805 | 164 | 17 | IPR007087 |
| Domain | FYrich_C | 7.53e-04 | 5 | 164 | 2 | IPR003889 | |
| Domain | FYrich_N | 7.53e-04 | 5 | 164 | 2 | IPR003888 | |
| Domain | FYRC | 7.53e-04 | 5 | 164 | 2 | SM00542 | |
| Domain | FYRN | 7.53e-04 | 5 | 164 | 2 | SM00541 | |
| Domain | FYRN | 7.53e-04 | 5 | 164 | 2 | PF05964 | |
| Domain | FYRC | 7.53e-04 | 5 | 164 | 2 | PF05965 | |
| Domain | FYRC | 7.53e-04 | 5 | 164 | 2 | PS51543 | |
| Domain | FYRN | 7.53e-04 | 5 | 164 | 2 | PS51542 | |
| Domain | ZnF_C2H2 | SP1 SP3 MAZ ZBTB22 ZBTB12 ZNF524 ZNF71 FOXP4 PRDM8 ZNF23 SALL1 ZNF608 ZNF852 ZNF592 GLI2 ZC3H7B ZNF839 | 7.67e-04 | 808 | 164 | 17 | SM00355 |
| Domain | BRCT | 9.05e-04 | 22 | 164 | 3 | SM00292 | |
| Domain | BRCT | 1.49e-03 | 26 | 164 | 3 | PS50172 | |
| Domain | AT_hook | 1.67e-03 | 27 | 164 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.67e-03 | 27 | 164 | 3 | IPR017956 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C NEK9 LPIN3 POM121 LMNA POM121B NUP153 | 1.95e-14 | 55 | 117 | 12 | MM14917 |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C NEK9 LPIN3 POM121 LMNA NUP153 | 4.54e-13 | 53 | 117 | 11 | M27212 |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C RING1 PARP1 POM121 HERC2 POM121B NUP153 | 4.11e-12 | 84 | 117 | 12 | MM14929 |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | SEH1L NUP98 TNRC6B NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 6.57e-12 | 49 | 117 | 10 | MM14837 |
| Pathway | REACTOME_SUMOYLATION | SEH1L SP3 NUP98 NUP62 NUP214 NUP58 POM121C RING1 PARP1 POM121 NR3C2 HERC2 POM121B NUP153 TP53BP1 | 8.89e-12 | 169 | 117 | 15 | MM14919 |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.07e-11 | 36 | 117 | 9 | M27245 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 3.02e-11 | 40 | 117 | 9 | MM14945 |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C RING1 PARP1 POM121 HERC2 NUP153 | 3.37e-11 | 77 | 117 | 11 | M27226 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 3.84e-11 | 41 | 117 | 9 | MM15200 |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C RING1 POM121 POM121B NUP153 | 3.92e-11 | 58 | 117 | 10 | MM15149 |
| Pathway | REACTOME_SUMOYLATION | SEH1L SP3 NUP98 NUP62 NUP214 NUP58 POM121C CREBBP RING1 PARP1 POM121 NR3C2 HERC2 NUP153 TP53BP1 | 4.45e-11 | 189 | 117 | 15 | M27214 |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 4.85e-11 | 42 | 117 | 9 | MM15039 |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 6.09e-11 | 43 | 117 | 9 | MM14609 |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C RING1 POM121 POM121B NUP153 | 1.28e-10 | 65 | 117 | 10 | MM15147 |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.43e-10 | 47 | 117 | 9 | M27395 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 1.43e-10 | 47 | 117 | 9 | MM14939 |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 1.57e-10 | 32 | 117 | 8 | M29579 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C NEK9 LPIN3 POM121 LMNA POM121B NUP153 | 1.63e-10 | 114 | 117 | 12 | MM15361 |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 2.06e-10 | 33 | 117 | 8 | M27016 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 2.58e-10 | 50 | 117 | 9 | MM14610 |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 2.68e-10 | 34 | 117 | 8 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 3.11e-10 | 51 | 117 | 9 | MM15151 |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 3.45e-10 | 35 | 117 | 8 | M27320 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 4.41e-10 | 36 | 117 | 8 | M26974 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 5.58e-10 | 37 | 117 | 8 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 5.58e-10 | 37 | 117 | 8 | M27038 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 8.78e-10 | 39 | 117 | 8 | M27238 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 1.04e-09 | 58 | 117 | 9 | MM14736 |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 1.34e-09 | 41 | 117 | 8 | M29574 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.01e-09 | 43 | 117 | 8 | M26975 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 2.44e-09 | 44 | 117 | 8 | M109 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 3.55e-09 | 46 | 117 | 8 | M27397 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 6.63e-09 | 71 | 117 | 9 | M27394 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 8.52e-09 | 73 | 117 | 9 | MM14948 |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | SEH1L COL4A6 NUP98 NUP62 NUP214 NUP58 POM121C CREBBP POM121 NUP153 | 1.07e-08 | 101 | 117 | 10 | M27253 |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.34e-08 | 54 | 117 | 8 | M29594 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 2.42e-08 | 82 | 117 | 9 | MM15394 |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.42e-08 | 82 | 117 | 9 | M27250 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C NEK9 LPIN3 POM121 LMNA NUP153 | 2.56e-08 | 142 | 117 | 11 | M27660 |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 2.76e-08 | 59 | 117 | 8 | M27606 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 3.69e-08 | 86 | 117 | 9 | MM15413 |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 6.68e-08 | 92 | 117 | 9 | MM14951 |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C CREBBP TOMM70 POM121 NUP153 | 9.03e-08 | 126 | 117 | 10 | M45009 |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 1.27e-07 | 99 | 117 | 9 | M27474 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 1.69e-07 | 74 | 117 | 8 | M48006 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | SEH1L NUP98 TNRC6B NUP62 NUP214 NUP58 TNRC6C POM121C POM121 NUP153 | 2.28e-07 | 139 | 117 | 10 | M715 |
| Pathway | REACTOME_HIV_LIFE_CYCLE | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C CHMP2A POM121 TAF5 NUP153 | 4.36e-07 | 149 | 117 | 10 | M4076 |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 4.56e-07 | 84 | 117 | 8 | M725 | |
| Pathway | REACTOME_HCMV_LATE_EVENTS | 4.97e-07 | 116 | 117 | 9 | M29806 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 5.00e-07 | 85 | 117 | 8 | M1870 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 1.35e-06 | 24 | 117 | 5 | MM15658 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.44e-06 | 68 | 117 | 7 | MM14921 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 2.52e-06 | 27 | 117 | 5 | M29807 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.71e-06 | 106 | 117 | 8 | M27458 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 3.09e-06 | 76 | 117 | 7 | M27215 | |
| Pathway | WP_PRADERWILLI_AND_ANGELMAN_SYNDROME | 3.35e-06 | 109 | 117 | 8 | M39542 | |
| Pathway | REACTOME_TRNA_PROCESSING | 3.84e-06 | 111 | 117 | 8 | M27684 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA | 4.36e-06 | 30 | 117 | 5 | M47752 | |
| Pathway | REACTOME_INFLUENZA_INFECTION | 6.21e-06 | 157 | 117 | 9 | M4669 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C CREBBP TOMM70 POM121 NUP153 | 7.51e-06 | 204 | 117 | 10 | M45011 |
| Pathway | REACTOME_HCMV_INFECTION | 8.01e-06 | 162 | 117 | 9 | M29804 | |
| Pathway | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | 1.31e-05 | 131 | 117 | 8 | M5283 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | CARM1 SEH1L COL4A6 SP1 EP400 NUP98 TNRC6B APOB NUP62 NUP214 CASTOR2 NUP58 TNRC6C POM121C CREBBP RING1 POM121 LMNA NR3C2 NUP153 | 1.43e-05 | 828 | 117 | 20 | M27827 |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 1.63e-05 | 177 | 117 | 9 | M27476 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 1.91e-05 | 138 | 117 | 8 | M29805 | |
| Pathway | REACTOME_M_PHASE | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C CHMP2A NEK9 LPIN3 POM121 LMNA POM121B NUP153 | 1.92e-05 | 387 | 117 | 13 | MM15364 |
| Pathway | REACTOME_HIV_INFECTION | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C CHMP2A POM121 TAF5 NUP153 | 2.22e-05 | 231 | 117 | 10 | M12469 |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 3.66e-05 | 151 | 117 | 8 | M550 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C CHMP2A CREBBP TOMM70 POM121 NUP153 | 3.84e-05 | 299 | 117 | 11 | M41727 |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | CARM1 SEH1L EP400 NUP98 APOB NUP62 NUP214 CASTOR2 NUP58 POM121C POM121 NR3C2 POM121B NUP153 | 7.47e-05 | 505 | 117 | 14 | MM15548 |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 ACAN POM121B NUP153 | 8.54e-05 | 271 | 117 | 10 | MM15406 |
| Pathway | BIOCARTA_NPC_PATHWAY | 8.76e-05 | 11 | 117 | 3 | M22033 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | FOXO3 SEH1L SP1 NUP98 TNRC6B WWTR1 NUP62 NUP214 NUP58 POM121C RING1 PARP1 ZNF23 POM121 ZNF852 KMT2A NR3C2 TAF5 ZNF839 POM121B NUP153 | 9.20e-05 | 1022 | 117 | 21 | MM15436 |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 SUGP1 POM121B NUP153 | 1.02e-04 | 277 | 117 | 10 | MM15414 |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 1.17e-04 | 58 | 117 | 5 | M11980 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 1.35e-04 | 32 | 117 | 4 | M48012 | |
| Pathway | REACTOME_CELL_CYCLE | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C CHMP2A NEK9 LPIN3 POM121 LMNA HERC2 POM121B NUP153 TP53BP1 | 1.37e-04 | 603 | 117 | 15 | MM14635 |
| Pathway | REACTOME_M_PHASE | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C CHMP2A NEK9 LPIN3 POM121 LMNA NUP153 | 1.78e-04 | 417 | 117 | 12 | M27662 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | CNTN4 SEH1L SP3 NAGK NUP98 MUC16 APOB NUP62 NUP214 NUP58 POM121C CREBBP RING1 ARSH TOMM70 PARP1 POM121 FGA NR3C2 HERC2 MUC4 UBE2Z FOXK1 NUP153 TP53BP1 | 3.85e-04 | 1475 | 117 | 25 | M19806 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | SEH1L SP3 NAGK NUP98 MUC19 MUC16 APOB NUP62 NUP214 NUP58 POM121C RING1 TOMM70 PARP1 POM121 FGA NR3C2 HERC2 POM121B MUC4 UBE2Z FOXK1 NUP153 TP53BP1 | 3.90e-04 | 1389 | 117 | 24 | MM15307 |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 4.33e-04 | 43 | 117 | 4 | M41827 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 4.48e-04 | 273 | 117 | 9 | M983 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 4.74e-04 | 44 | 117 | 4 | MM15678 | |
| Pathway | REACTOME_SARS_COV_INFECTIONS | SEH1L SP1 NUP98 NUP62 NUP214 NUP58 POM121C CHMP2A CREBBP TOMM70 POM121 NUP153 | 5.37e-04 | 471 | 117 | 12 | M39009 |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 5.81e-04 | 283 | 117 | 9 | M13087 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 6.58e-04 | 288 | 117 | 9 | M16864 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 6.64e-04 | 21 | 117 | 3 | MM15706 | |
| Pathway | WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE | 6.72e-04 | 5 | 117 | 2 | M45554 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 8.34e-04 | 51 | 117 | 4 | M665 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 9.01e-04 | 301 | 117 | 9 | MM15983 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 9.06e-04 | 90 | 117 | 5 | M820 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 1.00e-03 | 6 | 117 | 2 | MM1564 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 1.00e-03 | 6 | 117 | 2 | M22047 | |
| Pathway | BIOCARTA_TERT_PATHWAY | 1.40e-03 | 7 | 117 | 2 | MM1541 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.40e-03 | 7 | 117 | 2 | M46421 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 1.57e-03 | 28 | 117 | 3 | M48253 | |
| Pathway | REACTOME_CELL_CYCLE | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C CHMP2A NEK9 LPIN3 POM121 LMNA HERC2 NUP153 TP53BP1 | 1.81e-03 | 694 | 117 | 14 | M543 |
| Pathway | BIOCARTA_TERT_PATHWAY | 1.85e-03 | 8 | 117 | 2 | M22015 | |
| Pathway | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | 2.11e-03 | 31 | 117 | 3 | M669 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 2.23e-03 | 161 | 117 | 6 | M27871 | |
| Pubmed | SP1 EP400 NACC1 SCAF8 MAZ NUP98 DACH1 TNRC6B NUP62 NUP214 TNRC6C UBN2 POM121C CREBBP SLC1A5 RING1 TRIM33 FOXP4 SALL1 ZNF608 DCP1B ZNF592 GLI2 SUGP1 KMT2A MLLT6 TBXT PABPC1L HERC2 DOT1L TAF5 ILVBL FOXK1 TP53BP1 PRRC2B | 3.58e-15 | 1429 | 172 | 35 | 35140242 | |
| Pubmed | 1.34e-14 | 6 | 172 | 6 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 1.34e-14 | 6 | 172 | 6 | 25930072 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | ARGFX EP400 NUP98 NUP214 NUP58 UBN2 POM121C CREBBP RING1 TRIM33 TOMM70 FOXP4 SALL1 ZNF608 WDR6 KMT2A FOXK1 PRRC2B | 2.02e-13 | 351 | 172 | 18 | 38297188 |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | SEH1L NUP98 NUP62 NUP214 NUP58 POM121C POM121 POM121B NUP153 | 2.06e-13 | 38 | 172 | 9 | 12791264 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SEH1L ATXN2L EP400 NUP98 NUP62 NUP214 POM121C PARP1 POM121 LMNA CLPB SND1 ZNF592 WDR6 SCRIB HERC2 ARHGEF2 NUP153 TP53BP1 | 8.80e-13 | 440 | 172 | 19 | 34244565 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 FOXO3 PALD1 SYNRG EP400 KIF26A NUP214 TNRC6C POM121C PLXNB2 PRAG1 ADGRA2 BIRC6 SLC1A5 ADCY9 LPIN3 SND1 ZNF592 AHNAK MLLT6 HERC2 ARHGEF2 DOT1L ZC3H7B ZNF839 FOXK1 PRRC2B TJP3 | 1.30e-12 | 1105 | 172 | 28 | 35748872 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | PRUNE2 SP1 SP3 EP400 TRO NUP98 NUP214 TSC22D2 POM121C NEK9 SH2B1 POM121 SALL1 LMNA GLI2 AP5B1 MLLT6 NUP153 | 6.06e-12 | 430 | 172 | 18 | 35044719 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | CARM1 NAGK SCAF8 NUP98 TNRC6B WWTR1 NUP62 NUP214 NUP58 POM121C CREBBP TRIM33 POM121 LMNA DCP1B FOXK1 NUP153 PRRC2B | 1.65e-11 | 457 | 172 | 18 | 32344865 |
| Pubmed | 3.89e-11 | 26 | 172 | 7 | 12228227 | ||
| Pubmed | CCNL2 ATP7B EP400 CENPB NACC1 MAZ TNRC6B POM121C KANK2 CHMP2A CREBBP ADCY9 TRIM33 ARHGAP4 FOXP4 ZNF608 ZNF592 WDR6 CRNN FMN2 TIGD5 SCRIB TAF5 ILVBL FOXK1 PRRC2B | 5.67e-11 | 1116 | 172 | 26 | 31753913 | |
| Pubmed | 6.46e-11 | 15 | 172 | 6 | 14697343 | ||
| Pubmed | ATXN2L SYNRG EP400 DACH1 TNRC6B WWTR1 UBN2 CREBBP NEK9 SND1 WDR6 AHNAK KMT2A SCRIB DOT1L TAF5 TP53BP1 PRRC2B | 3.22e-10 | 549 | 172 | 18 | 38280479 | |
| Pubmed | CARM1 RABEP2 TPP2 CNTN4 HCN4 NACC1 HCN1 ZBTB22 TNRC6B NCAM1 UBN2 KANK2 NEK9 KIAA0319 PARP1 SCRIB HERC2 ARHGEF2 TAF5 NUP153 MAPK8IP2 TP53BP1 PRRC2B | 5.02e-10 | 963 | 172 | 23 | 28671696 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | PALD1 ATXN2L SYNRG EP400 NACC1 NUP98 TNRC6B NUP62 NUP214 POM121C NEK9 SLC1A5 PARP1 TRIR SND1 AHNAK SUGP1 KMT2A SCRIB NUP153 TP53BP1 PRRC2B | 1.59e-09 | 934 | 172 | 22 | 33916271 |
| Pubmed | 1.68e-09 | 24 | 172 | 6 | 32212159 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXO3 FOXO3B EP400 CENPB NACC1 TRO NUP98 DACH1 WWTR1 ISL1 KANK2 CREBBP SH2B1 TRIM33 TOMM70 FOXP4 SALL1 SCRIB ARHGEF2 FOXK1 TP53BP1 | 1.93e-09 | 857 | 172 | 21 | 25609649 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO3 ATXN2L SYNRG MAZ WWTR1 NUP62 PRAG1 NEK9 SLC1A5 LPIN3 DCP1B STARD9 AHNAK NECTIN2 FMN2 KMT2A NR3C2 SCRIB ARHGEF2 FOXK1 SAMD4A | 2.09e-09 | 861 | 172 | 21 | 36931259 |
| Pubmed | 2.20e-09 | 25 | 172 | 6 | 10601273 | ||
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | 4.78e-09 | 77 | 172 | 8 | 24927568 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SYNRG EP400 DACH1 TNRC6B UBN2 CREBBP SLC1A5 TRIM33 PARP1 SALL1 LMNA ZNF608 AHNAK SUGP1 FOXK1 | 6.92e-09 | 444 | 172 | 15 | 34795231 |
| Pubmed | Integrated structural analysis of the human nuclear pore complex scaffold. | 7.21e-09 | 30 | 172 | 6 | 24315095 | |
| Pubmed | 7.21e-09 | 30 | 172 | 6 | 27016207 | ||
| Pubmed | EP400 NACC1 MAZ NUP98 NUP214 ZNF524 BIRC6 TRIM33 TRIR ZNF592 AHNAK KMT2A MUC4 BAG6 TP53BP1 | 1.43e-08 | 469 | 172 | 15 | 27634302 | |
| Pubmed | MKRN4P SP1 SP3 CENPB ZBTB22 ISL1 BIRC6 CREBBP RING1 FOXP4 ZNF23 OTX1 GLI2 KMT2A TBXT NR3C2 TIGD5 FOXK1 | 1.74e-08 | 709 | 172 | 18 | 22988430 | |
| Pubmed | 2.00e-08 | 7 | 172 | 4 | 11238447 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | SEH1L ATXN2L CENPB MAZ NUP98 NUP62 NUP214 SLC1A5 PARP1 CLPB DCP1B SND1 PHLPP1 SCRIB HERC2 ARHGEF2 BAG6 FOXK1 NUP153 TP53BP1 PRRC2B | 3.04e-08 | 1005 | 172 | 21 | 19615732 |
| Pubmed | Imaging within single NPCs reveals NXF1's role in mRNA export on the cytoplasmic side of the pore. | 3.98e-08 | 8 | 172 | 4 | 31375530 | |
| Pubmed | Lamin B1 protein is required for dendrite development in primary mouse cortical neurons. | 3.98e-08 | 8 | 172 | 4 | 26510501 | |
| Pubmed | 4.48e-08 | 40 | 172 | 6 | 37516964 | ||
| Pubmed | 4.81e-08 | 68 | 172 | 7 | 29091030 | ||
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | SCAF8 TNRC6B NCAM1 TNRC6C PLXNB2 CREBBP SLC1A5 TRIR EPHA2 NECTIN2 SLAIN1 PRRC2B | 4.86e-08 | 307 | 172 | 12 | 37499664 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | ATXN2L NUP98 NUP214 KANK2 SLC1A5 SND1 EPHA2 AHNAK SUGP1 PHLPP1 SCRIB | 6.88e-08 | 256 | 172 | 11 | 33397691 |
| Pubmed | 7.14e-08 | 9 | 172 | 4 | 9114010 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | FOXO3 SP1 SP3 ARGFX ZBTB22 ZBTB12 ISL1 ZNF524 HMX2 ZNF23 OTX1 GLI2 TBXT NR3C2 FOXK1 | 9.94e-08 | 544 | 172 | 15 | 28473536 |
| Pubmed | 1.19e-07 | 10 | 172 | 4 | 19581287 | ||
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 34101965 | ||
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 35507432 | ||
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 9847314 | ||
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 15777284 | ||
| Pubmed | The nuclear pore complex: a new dynamic in HIV-1 replication. | 1.19e-07 | 3 | 172 | 3 | 21327100 | |
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 1.19e-07 | 3 | 172 | 3 | 30802453 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SEH1L SP1 EP400 MAZ NUP98 WWTR1 NUP62 NUP214 UBN2 POM121C RING1 PARP1 OTX1 LMNA TBRG1 AHNAK KMT2A TIGD5 TAF5 ILVBL FOXK1 NUP153 SAMD4A | 1.20e-07 | 1294 | 172 | 23 | 30804502 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXO3 SP1 SP3 ARGFX MAZ ISL1 TSC22D2 ZNF524 HMX2 FOXP4 TSC22D1 ZNF23 OTX1 SALL1 GLI2 KMT2A TBXT NR3C2 FOXK1 | 1.42e-07 | 908 | 172 | 19 | 19274049 |
| Pubmed | TPP2 SEH1L ATXN2L EP400 NACC1 DACH1 UBN2 CREBBP TRIM33 PARP1 TRIR SND1 SUGP1 KMT2A MLLT6 ARHGEF2 BAG6 FOXK1 NUP153 TP53BP1 PRRC2B | 1.44e-07 | 1103 | 172 | 21 | 34189442 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.93e-07 | 123 | 172 | 8 | 26912792 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ATXN2L EP400 MAZ NUP98 DACH1 NUP62 NUP214 UBN2 TRIM33 PARP1 TRIR SALL1 LMNA AHNAK SUGP1 KMT2A MLLT6 NUP153 TP53BP1 | 3.01e-07 | 954 | 172 | 19 | 36373674 |
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 4.74e-07 | 4 | 172 | 3 | 17900573 | |
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 15219855 | ||
| Pubmed | Biallelic mutations in nucleoporin NUP88 cause lethal fetal akinesia deformation sequence. | 4.74e-07 | 4 | 172 | 3 | 30543681 | |
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 24739174 | ||
| Pubmed | 5.56e-07 | 14 | 172 | 4 | 11073998 | ||
| Pubmed | CARM1 CCNL2 FOXO3 ATXN2L SP1 SP3 NACC1 PCDHA13 GJC2 NUP214 TSC22D2 BIRC6 PARP1 TRIR SALL1 CLPB SUGP1 PHLPP1 KMT2A SLC23A1 BAG6 FOXK1 | 7.41e-07 | 1327 | 172 | 22 | 32694731 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 8.51e-07 | 203 | 172 | 9 | 22083510 | |
| Pubmed | CCNL2 ZBTB22 CREBBP PARP1 LMNA WDR6 AHNAK SCRIB ARHGEF2 FOXK1 PRRC2B | 9.15e-07 | 332 | 172 | 11 | 37433992 | |
| Pubmed | PALD1 EP400 SCAF8 TRO TNRC6B NUP214 TNRC6C KIAA0319 TOMM70 STARD9 SCRIB PRRC2B | 9.87e-07 | 407 | 172 | 12 | 12693553 | |
| Pubmed | EP400 UBN2 CREBBP TRIM33 FOXP4 ZNF608 SUGP1 KMT2A FOXK1 PRRC2B | 9.99e-07 | 268 | 172 | 10 | 33640491 | |
| Pubmed | SP1 KIF26A NUP98 WWTR1 NUP214 NUP58 POM121C CREBBP TSC22D1 POM121 HERC2 ZNF839 NUP153 | 1.02e-06 | 486 | 172 | 13 | 20936779 | |
| Pubmed | 1.18e-06 | 5 | 172 | 3 | 19828735 | ||
| Pubmed | Dynein Light Chain 1 (DYNLT1) Interacts with Normal and Oncogenic Nucleoporins. | 1.18e-06 | 5 | 172 | 3 | 23840580 | |
| Pubmed | 1.18e-06 | 5 | 172 | 3 | 10362258 | ||
| Pubmed | 1.18e-06 | 5 | 172 | 3 | 16730000 | ||
| Pubmed | 1.18e-06 | 5 | 172 | 3 | 12192052 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | TPP2 ATP7B NUP98 TNRC6B NUP62 NUP214 NUP58 TNRC6C KANK2 NEK9 TOMM70 SND1 HERC2 BAG6 NUP153 PRRC2B | 1.21e-06 | 754 | 172 | 16 | 33060197 |
| Pubmed | CARM1 TPP2 ATXN2L OGFR TNRC6B NUP214 TNRC6C PARP1 LMNA SND1 AHNAK NUP153 TP53BP1 | 1.23e-06 | 494 | 172 | 13 | 26831064 | |
| Pubmed | RABEP2 TPP2 RELCH MAZ NUP98 BIRC6 SLC1A5 ADCY9 TOMM70 PARP1 AHNAK NECTIN2 PHLPP1 FMN2 SCRIB HERC2 ARHGEF2 NUP153 PRRC2B | 1.24e-06 | 1049 | 172 | 19 | 27880917 | |
| Pubmed | 1.31e-06 | 17 | 172 | 4 | 10668806 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATXN2L SP1 SYNRG EP400 NACC1 SCAF8 NUP98 NUP214 LMNA ZNF592 KMT2A SCRIB ARHGEF2 BAG6 NUP153 TP53BP1 | 1.69e-06 | 774 | 172 | 16 | 15302935 |
| Pubmed | EP400 NUP98 MUC16 TNRC6B NCAM1 APOB BIRC6 SLC1A5 ADCY9 TRIM33 EPHA2 AHNAK NECTIN2 SLITRK5 SCRIB PRRC2B | 1.78e-06 | 777 | 172 | 16 | 35844135 | |
| Pubmed | 1.79e-06 | 222 | 172 | 9 | 37071664 | ||
| Pubmed | 1.99e-06 | 225 | 172 | 9 | 12168954 | ||
| Pubmed | Activation of mouse RAG-2 promoter by Myc-associated zinc finger protein. | 2.35e-06 | 6 | 172 | 3 | 15094381 | |
| Pubmed | 2.35e-06 | 6 | 172 | 3 | 11266456 | ||
| Pubmed | 2.35e-06 | 6 | 172 | 3 | 16734381 | ||
| Pubmed | 2.52e-06 | 121 | 172 | 7 | 22412018 | ||
| Pubmed | CARM1 PALD1 ATXN2L TNRC6B NUP214 SLC1A5 ADCY9 PARP1 SND1 EPHA2 AHNAK NECTIN2 SLITRK5 SCRIB NUP153 | 2.69e-06 | 708 | 172 | 15 | 39231216 | |
| Pubmed | 3.25e-06 | 46 | 172 | 5 | 35022314 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 3.45e-06 | 180 | 172 | 8 | 35198878 | |
| Pubmed | PALD1 ATXN2L ATP7B EP400 SCAF8 MFSD9 TNRC6B NUP214 KANK2 BIRC6 ADCY9 DCP1B WDR6 SUGP1 ARHGEF2 | 4.09e-06 | 733 | 172 | 15 | 34672954 | |
| Pubmed | Sall1 transiently marks undifferentiated heart precursors and regulates their fate. | 4.10e-06 | 7 | 172 | 3 | 26876450 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | SEH1L ATXN2L OGFR NUP98 NUP62 NUP214 PLXNB2 SLC1A4 TOMM70 PARP1 FCGBP SND1 EPHA2 AHNAK NECTIN2 SCRIB UBE2Z ILVBL FOXK1 TP53BP1 PRRC2B | 4.43e-06 | 1367 | 172 | 21 | 32687490 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | ATXN2L ABI3 SCAF8 TNRC6B NUP214 CHMP2A CLPB WDR6 FMN2 HERC2 TP53BP1 PRRC2B | 4.83e-06 | 475 | 172 | 12 | 31040226 |
| Pubmed | TPP2 ATXN2L NUP98 NUP214 BIRC6 LMNA SND1 WDR6 AHNAK KMT2A HERC2 NUP153 TP53BP1 PRRC2B | 5.13e-06 | 653 | 172 | 14 | 22586326 | |
| Pubmed | Poly(ADP-ribose) polymerase 1 (PARP-1) binds to 8-oxoguanine-DNA glycosylase (OGG1). | 6.54e-06 | 8 | 172 | 3 | 22057269 | |
| Pubmed | 6.54e-06 | 8 | 172 | 3 | 8069910 | ||
| Pubmed | 7.25e-06 | 54 | 172 | 5 | 35391932 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | EP400 MAZ SLC1A5 RING1 PARP1 OTX1 SALL1 LMNA ZNF592 SCRIB TAF5 FOXK1 TP53BP1 | 7.42e-06 | 583 | 172 | 13 | 29844126 |
| Pubmed | 9.77e-06 | 9 | 172 | 3 | 38386912 | ||
| Pubmed | Pellino1 specifically binds to phospho-Thr18 of p53 and is recruited to sites of DNA damage. | 9.77e-06 | 9 | 172 | 3 | 30987826 | |
| Pubmed | Cellular cofactors of lentiviral integrase: from target validation to drug discovery. | 9.77e-06 | 9 | 172 | 3 | 22928108 | |
| Pubmed | TPP2 PALD1 CENPB MAZ NUP62 UBN2 SLC1A5 TOMM70 PARP1 LMNA CLPB SND1 WDR6 AHNAK KMT2A SCRIB ARHGEF2 BAG6 ILVBL PRRC2B SAMD4A | 9.77e-06 | 1440 | 172 | 21 | 30833792 | |
| Pubmed | TRO NUP98 APOB NUP62 SSR2 CCDC57 MINDY2 RING1 RGS14 PARP1 PRDM8 LMNA ZNF608 SND1 UMODL1 STARD9 AHNAK KMT2A PABPC1L ARHGEF2 PRRC2B | 9.98e-06 | 1442 | 172 | 21 | 35575683 | |
| Pubmed | 1.13e-05 | 152 | 172 | 7 | 38360978 | ||
| Pubmed | 1.36e-05 | 104 | 172 | 6 | 10470851 | ||
| Pubmed | 1.39e-05 | 10 | 172 | 3 | 18596238 | ||
| Pubmed | 1.39e-05 | 10 | 172 | 3 | 27396331 | ||
| Pubmed | 1.39e-05 | 10 | 172 | 3 | 17565040 | ||
| Pubmed | Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. | 1.39e-05 | 10 | 172 | 3 | 15619633 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EP400 NUP98 NUP62 NUP214 NUP58 PLXNB2 SLC1A5 PARP1 POM121 LMNA SND1 AHNAK SCRIB HERC2 ARHGEF2 BAG6 NUP153 | 1.44e-05 | 1024 | 172 | 17 | 24711643 |
| Pubmed | CARM1 SEH1L NAGK NUP98 NUP62 NUP214 UBN2 CREBBP TOMM70 POM121 HERC2 FOXK1 | 1.53e-05 | 533 | 172 | 12 | 25544563 | |
| Interaction | SIRT6 interactions | FOXO3 SEH1L ATXN2L EP400 NUP98 NUP62 NUP214 POM121C CREBBP PARP1 POM121 LMNA CLPB SND1 ZNF592 WDR6 SCRIB HERC2 ARHGEF2 BAG6 NUP153 TP53BP1 | 1.70e-08 | 628 | 170 | 22 | int:SIRT6 |
| Interaction | NUP35 interactions | SEH1L NAGK SCAF8 NUP98 TNRC6B WWTR1 NUP62 NUP214 NUP58 POM121C CREBBP TRIM33 POM121 LMNA DCP1B FOXK1 NUP153 PRRC2B | 2.11e-08 | 424 | 170 | 18 | int:NUP35 |
| Interaction | FEV interactions | EP400 DACH1 UBN2 CREBBP RING1 FOXP4 SALL1 ZNF608 KMT2A TAF5 FOXK1 PRRC2B | 1.60e-07 | 203 | 170 | 12 | int:FEV |
| Interaction | CRX interactions | SP1 SP3 EP400 UBN2 KANK2 CREBBP TRIM33 FOXP4 SALL1 ZNF608 MLLT6 FOXK1 PRRC2B | 2.56e-07 | 254 | 170 | 13 | int:CRX |
| Interaction | TOP3B interactions | VWA5B2 FOXO3 PALD1 SYNRG EP400 KIF26A TNRC6B APOB NUP214 TNRC6C POM121C PLXNB2 PRAG1 KANK2 ADGRA2 BIRC6 SLC1A5 ADCY9 LPIN3 SND1 ZNF592 AHNAK MLLT6 HERC2 ARHGEF2 DOT1L ZC3H7B ZNF839 FOXK1 TP53BP1 PRRC2B TJP3 | 6.11e-07 | 1470 | 170 | 32 | int:TOP3B |
| Interaction | POU5F1 interactions | TPP2 SP1 EP400 NACC1 SCAF8 MUC16 UBN2 TRIM33 PARP1 FOXP4 SALL1 SND1 GLI2 AHNAK SUGP1 BAG6 TP53BP1 PRRC2B | 2.32e-06 | 584 | 170 | 18 | int:POU5F1 |
| Interaction | UBE2I interactions | CARM1 SEH1L SP3 NACC1 NUP98 DACH1 NUP214 CREBBP TRIM33 PARP1 SALL1 LMNA SND1 GLI2 SUGP1 NR3C2 TAF5 NUP153 TP53BP1 | 2.84e-06 | 654 | 170 | 19 | int:UBE2I |
| Interaction | NUP93 interactions | SEH1L SP1 NUP98 NUP62 NUP214 NUP58 CREBBP RING1 TSC22D1 LMNA DOT1L NUP153 | 3.16e-06 | 269 | 170 | 12 | int:NUP93 |
| Interaction | SMG7 interactions | NACC1 SCAF8 DACH1 TNRC6B WWTR1 TNRC6C CREBBP RING1 SALL1 ZNF608 MLLT6 DOT1L PRRC2B | 3.30e-06 | 319 | 170 | 13 | int:SMG7 |
| Interaction | CREBBP interactions | CARM1 FOXO3 SP1 SP3 ARGFX NUP98 DACH1 WWTR1 CREBBP SLC1A4 TRIM33 PARP1 SND1 ZNF592 KMT2A TBXT NR3C2 TP53BP1 | 3.31e-06 | 599 | 170 | 18 | int:CREBBP |
| Interaction | EN1 interactions | 4.29e-06 | 110 | 170 | 8 | int:EN1 | |
| Interaction | KLF8 interactions | SP1 EP400 MAZ UBN2 POM121C CREBBP RING1 TRIM33 PARP1 FOXP4 TAF5 FOXK1 PRRC2B | 4.61e-06 | 329 | 170 | 13 | int:KLF8 |
| Interaction | NUP43 interactions | SEH1L ARGFX EP400 NUP98 MUC19 TNRC6B NUP62 NUP214 UBN2 POM121C POM121 LMNA ZNF608 SND1 ZNF592 KMT2A MLLT6 NUP153 | 5.95e-06 | 625 | 170 | 18 | int:NUP43 |
| Interaction | SEH1L interactions | 8.01e-06 | 158 | 170 | 9 | int:SEH1L | |
| Interaction | NAA40 interactions | TPP2 PALD1 ATXN2L SYNRG EP400 NACC1 NUP98 TNRC6B NUP62 NUP214 POM121C NEK9 SLC1A5 PARP1 TRIR SND1 AHNAK SUGP1 KMT2A SCRIB NUP153 TP53BP1 PRRC2B | 8.36e-06 | 978 | 170 | 23 | int:NAA40 |
| Interaction | SP7 interactions | EP400 NACC1 SCAF8 CREBBP RING1 TRIM33 FOXP4 ZNF608 EPHA2 SUGP1 FOXK1 PRRC2B | 1.10e-05 | 304 | 170 | 12 | int:SP7 |
| Interaction | NFIC interactions | DACH1 CREBBP PARP1 FOXP4 LMNA ZNF608 EPHA2 TBXT DOT1L TP53BP1 | 1.22e-05 | 210 | 170 | 10 | int:NFIC |
| Interaction | NUP153 interactions | SEH1L NUP98 NUP62 NUP214 POM121C POM121 LMNA HERC2 DOT1L NUP153 | 1.55e-05 | 216 | 170 | 10 | int:NUP153 |
| Interaction | NUP98 interactions | SEH1L NUP98 NUP62 NUP214 NUP58 CREBBP LMNA PHLPP1 DOT1L NUP153 | 1.82e-05 | 220 | 170 | 10 | int:NUP98 |
| Interaction | HDAC1 interactions | RABEP2 CCNL2 SP1 SP3 EP400 NUP98 DACH1 TNRC6B NUP214 BIRC6 CREBBP NEK9 RING1 PARP1 SALL1 ZNF608 ZNF592 WDR6 GLI2 AHNAK PHLPP1 KMT2A DOT1L FOXK1 | 2.04e-05 | 1108 | 170 | 24 | int:HDAC1 |
| Interaction | NXF1 interactions | TPP2 SEH1L SP1 SCAF8 MAZ NUP98 DACH1 TNRC6B NUP62 NUP214 SSR2 NUP58 POM121C PARP1 ZNF23 POM121 LMNA AHNAK SUGP1 SLAIN1 SCRIB ARHGEF2 ZC3H7B UBE2Z NUP153 TP53BP1 PRRC2B | 2.27e-05 | 1345 | 170 | 27 | int:NXF1 |
| Interaction | HNF4A interactions | SP1 EP400 DACH1 MUC19 ISL1 UBN2 CREBBP RING1 TRIM33 ZNF608 TAF5 | 2.27e-05 | 275 | 170 | 11 | int:HNF4A |
| Interaction | DTX2 interactions | SCAF8 NUP98 WWTR1 NUP58 POM121C CCDC57 KANK2 PARP1 LMNA NECTIN2 SLITRK5 NUP153 | 2.47e-05 | 330 | 170 | 12 | int:DTX2 |
| Interaction | ETV6 interactions | 3.05e-05 | 105 | 170 | 7 | int:ETV6 | |
| Interaction | NUP50 interactions | NACC1 NUP98 DACH1 NUP214 TRIM33 TSC22D1 POM121 LMNA SUGP1 KMT2A NUP153 TP53BP1 | 3.40e-05 | 341 | 170 | 12 | int:NUP50 |
| Interaction | HNF1B interactions | 3.48e-05 | 190 | 170 | 9 | int:HNF1B | |
| Interaction | KLF15 interactions | EP400 MAZ CCDC57 CREBBP RING1 FOXP4 ZNF608 GLI2 TAF5 FOXK1 PRRC2B | 3.70e-05 | 290 | 170 | 11 | int:KLF15 |
| Interaction | KLF5 interactions | 4.27e-05 | 195 | 170 | 9 | int:KLF5 | |
| Interaction | NUP214 interactions | 4.27e-05 | 195 | 170 | 9 | int:NUP214 | |
| Interaction | BRCA1 interactions | CARM1 CCNL2 FOXO3 TPP2 CNTN4 ATXN2L SP1 CENPB OGFR TNRC6B NUP214 TNRC6C CREBBP SH2B1 TRIM33 PARP1 POM121 LMNA SND1 WDR6 AHNAK SAGE1 HERC2 NUP153 TP53BP1 | 4.98e-05 | 1249 | 170 | 25 | int:BRCA1 |
| Interaction | NUP85 interactions | 5.47e-05 | 156 | 170 | 8 | int:NUP85 | |
| Interaction | RANBP2 interactions | SEH1L NUP98 NUP62 NUP214 NUP58 CHMP2A TRIM33 LMNA SUGP1 PHLPP1 DOT1L NUP153 | 5.90e-05 | 361 | 170 | 12 | int:RANBP2 |
| Interaction | WWTR1 interactions | ATXN2L SYNRG EP400 TNRC6B WWTR1 CREBBP NEK9 SND1 WDR6 KMT2A SCRIB TP53BP1 PRRC2B | 6.30e-05 | 422 | 170 | 13 | int:WWTR1 |
| Interaction | PAX6 interactions | EP400 DACH1 APOB UBN2 KANK2 CREBBP RING1 SALL1 ZNF608 MLLT6 FOXK1 PRRC2B | 6.73e-05 | 366 | 170 | 12 | int:PAX6 |
| Interaction | SOX7 interactions | 6.80e-05 | 82 | 170 | 6 | int:SOX7 | |
| Interaction | TLE3 interactions | SCAF8 UBN2 CREBBP POM121 SALL1 ZNF608 GLI2 KMT2A MLLT6 TBXT SAGE1 DOT1L | 8.69e-05 | 376 | 170 | 12 | int:TLE3 |
| Interaction | EGR2 interactions | 1.04e-04 | 171 | 170 | 8 | int:EGR2 | |
| Interaction | SYNE3 interactions | SYNRG NUP98 TNRC6B NUP62 NUP214 NUP58 TNRC6C POM121C KANK2 ADCY9 DCP1B SLAIN1 PRRC2B | 1.05e-04 | 444 | 170 | 13 | int:SYNE3 |
| Interaction | SLX4 interactions | EP400 CENPB ZBTB12 NUP214 UBN2 CREBBP TRIM33 PARP1 SALL1 LMNA SUGP1 ARHGEF2 NUP153 TP53BP1 PRRC2B | 1.06e-04 | 572 | 170 | 15 | int:SLX4 |
| Interaction | NUP107 interactions | 1.12e-04 | 221 | 170 | 9 | int:NUP107 | |
| Interaction | SLC1A4 interactions | 1.13e-04 | 30 | 170 | 4 | int:SLC1A4 | |
| Interaction | TLX1 interactions | 1.22e-04 | 175 | 170 | 8 | int:TLX1 | |
| Interaction | NUP133 interactions | 1.22e-04 | 175 | 170 | 8 | int:NUP133 | |
| Interaction | TEAD1 interactions | 1.27e-04 | 176 | 170 | 8 | int:TEAD1 | |
| Interaction | PHLPP1 interactions | ATXN2L NUP98 NUP214 KANK2 SLC1A5 SND1 EPHA2 AHNAK SUGP1 PHLPP1 SCRIB | 1.27e-04 | 333 | 170 | 11 | int:PHLPP1 |
| Interaction | NUP58 interactions | 1.29e-04 | 92 | 170 | 6 | int:NUP58 | |
| Interaction | NKX2-1 interactions | 1.48e-04 | 180 | 170 | 8 | int:NKX2-1 | |
| Interaction | YWHAH interactions | FOXO3 ATXN2L SYNRG MAZ WWTR1 NUP62 PRAG1 CREBBP SLC1A5 LPIN3 DCP1B STARD9 AHNAK NECTIN2 FMN2 KMT2A SLAIN1 NR3C2 SCRIB ARHGEF2 FOXK1 SAMD4A | 1.53e-04 | 1102 | 170 | 22 | int:YWHAH |
| Interaction | ZFP36 interactions | 1.54e-04 | 181 | 170 | 8 | int:ZFP36 | |
| Interaction | KANK2 interactions | ABI3 PELI3 TNRC6B CCDC57 KANK2 PARP1 DCP1B PHLPP1 DOT1L FOXK1 | 1.59e-04 | 285 | 170 | 10 | int:KANK2 |
| Interaction | PHF21A interactions | SP3 TNRC6B NUP62 NUP214 NUP58 BIRC6 NEK9 SALL1 ZNF592 WDR6 AHNAK | 1.65e-04 | 343 | 170 | 11 | int:PHF21A |
| Interaction | SUMO1 interactions | SEH1L SP3 CREBBP PARP1 SALL1 GLI2 PHLPP1 NR3C2 NUP153 TP53BP1 | 1.68e-04 | 287 | 170 | 10 | int:SUMO1 |
| Interaction | HDAC4 interactions | ATXN2L SP1 ABI3 NACC1 SCAF8 TNRC6B NUP214 CHMP2A LPIN3 PARP1 CLPB WDR6 GLI2 FMN2 HERC2 TP53BP1 PRRC2B | 1.92e-04 | 744 | 170 | 17 | int:HDAC4 |
| Interaction | GATA3 interactions | 1.93e-04 | 187 | 170 | 8 | int:GATA3 | |
| Interaction | ERVW-1 interactions | 2.11e-04 | 3 | 170 | 2 | int:ERVW-1 | |
| Interaction | SMARCC2 interactions | CARM1 SP1 CREBBP TRIM33 ARHGAP4 PARP1 KMT2A TBXT DOT1L NUP153 TP53BP1 | 2.11e-04 | 353 | 170 | 11 | int:SMARCC2 |
| Interaction | NUP155 interactions | SEH1L NUP98 TNRC6B NUP62 NUP214 NUP58 POM121C ADCY9 POM121 LMNA EPHA2 SLAIN1 NUP153 | 2.12e-04 | 477 | 170 | 13 | int:NUP155 |
| Interaction | PELI1 interactions | 2.21e-04 | 65 | 170 | 5 | int:PELI1 | |
| Interaction | NUP37 interactions | 2.21e-04 | 65 | 170 | 5 | int:NUP37 | |
| Interaction | NANOG interactions | TPP2 ATXN2L SP1 EP400 NACC1 MUC16 ZNF524 TRIM33 PARP1 SALL1 SUGP1 DOT1L TP53BP1 | 2.30e-04 | 481 | 170 | 13 | int:NANOG |
| Interaction | FBXO38 interactions | 2.34e-04 | 145 | 170 | 7 | int:FBXO38 | |
| Interaction | MYOD1 interactions | 2.48e-04 | 194 | 170 | 8 | int:MYOD1 | |
| Interaction | DPPA3 interactions | 2.55e-04 | 67 | 170 | 5 | int:DPPA3 | |
| Interaction | KPNA3 interactions | 2.65e-04 | 248 | 170 | 9 | int:KPNA3 | |
| Interaction | NUP188 interactions | 2.65e-04 | 148 | 170 | 7 | int:NUP188 | |
| Interaction | FOXL1 interactions | 2.65e-04 | 196 | 170 | 8 | int:FOXL1 | |
| Interaction | CDC27 interactions | 2.73e-04 | 249 | 170 | 9 | int:CDC27 | |
| Interaction | ASF1A interactions | 2.73e-04 | 249 | 170 | 9 | int:ASF1A | |
| Interaction | ANAPC10 interactions | 2.73e-04 | 68 | 170 | 5 | int:ANAPC10 | |
| Interaction | GLE1 interactions | 2.87e-04 | 150 | 170 | 7 | int:GLE1 | |
| Interaction | CUX1 interactions | 2.94e-04 | 199 | 170 | 8 | int:CUX1 | |
| Interaction | ARHGEF7 interactions | 3.24e-04 | 153 | 170 | 7 | int:ARHGEF7 | |
| Interaction | RAB2A interactions | CARM1 RELCH NCAM1 PLXNB2 CHMP2A SLC1A5 ADCY9 RGS14 LMNA WDR6 EPHA2 NECTIN2 FMN2 SLC26A11 | 3.33e-04 | 567 | 170 | 14 | int:RAB2A |
| Interaction | CTNNB1 interactions | CARM1 FOXO3 ATXN2L SP1 EP400 NUP98 NUP214 CREBBP TRIM33 RGS14 PARP1 TSC22D1 SALL1 LMNA SND1 EPHA2 KMT2A SCRIB HERC2 DOT1L | 3.40e-04 | 1009 | 170 | 20 | int:CTNNB1 |
| Interaction | DPY30 interactions | 3.47e-04 | 204 | 170 | 8 | int:DPY30 | |
| Interaction | SPDL1 interactions | TPP2 PALD1 ATXN2L WWTR1 NEK9 AHNAK PHLPP1 SLAIN1 BAG6 TP53BP1 | 3.54e-04 | 315 | 170 | 10 | int:SPDL1 |
| Interaction | TRRAP interactions | FOXO3 SEH1L EP400 SCAF8 WWTR1 APOB NUP214 KANK2 CREBBP TRIM33 TOMM70 PARP1 POM121 CLPB DOT1L TAF5 ILVBL | 3.85e-04 | 790 | 170 | 17 | int:TRRAP |
| Interaction | SMAD3 interactions | FOXO3 ATXN2L SP1 DACH1 APOB NUP214 ISL1 CREBBP TRIM33 PARP1 LMNA NUP153 | 4.26e-04 | 447 | 170 | 12 | int:SMAD3 |
| Interaction | GPBP1 interactions | 4.32e-04 | 75 | 170 | 5 | int:GPBP1 | |
| Interaction | SMARCC1 interactions | CARM1 SP1 NACC1 WWTR1 CREBBP TRIM33 PARP1 OTX1 KMT2A TBXT TP53BP1 | 4.32e-04 | 384 | 170 | 11 | int:SMARCC1 |
| Interaction | MEX3A interactions | CCNL2 ZBTB22 CREBBP PARP1 LMNA WDR6 AHNAK SCRIB ARHGEF2 FOXK1 PRRC2B | 4.32e-04 | 384 | 170 | 11 | int:MEX3A |
| Interaction | SMAD2 interactions | FOXO3 SP1 NAGK WWTR1 NUP214 CREBBP TRIM33 PARP1 EPHA2 TAF5 NUP153 | 4.41e-04 | 385 | 170 | 11 | int:SMAD2 |
| Interaction | CTIF interactions | 4.87e-04 | 77 | 170 | 5 | int:CTIF | |
| Interaction | YY1 interactions | ATXN2L SP1 SP3 EP400 CREBBP RING1 PARP1 FOXP4 ZNF592 KMT2A DOT1L TAF5 | 4.89e-04 | 454 | 170 | 12 | int:YY1 |
| Interaction | COG6 interactions | 4.93e-04 | 164 | 170 | 7 | int:COG6 | |
| Interaction | RND3 interactions | 5.33e-04 | 273 | 170 | 9 | int:RND3 | |
| GeneFamily | Nucleoporins | 1.17e-09 | 32 | 117 | 7 | 1051 | |
| GeneFamily | CD molecules|Mucins | 3.23e-04 | 21 | 117 | 3 | 648 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 5.47e-04 | 25 | 117 | 3 | 775 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | SP1 SP3 MAZ ZBTB22 ZBTB12 ZNF524 ZNF71 ZNF23 SALL1 ZNF608 ZNF852 ZNF592 GLI2 | 7.60e-04 | 718 | 117 | 13 | 28 |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.37e-03 | 34 | 117 | 3 | 487 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 1.45e-03 | 9 | 117 | 2 | 755 | |
| GeneFamily | Cyclic nucleotide gated channels | 1.81e-03 | 10 | 117 | 2 | 250 | |
| GeneFamily | Forkhead boxes | 2.70e-03 | 43 | 117 | 3 | 508 | |
| GeneFamily | Helix-turn-helix CENPB type domain containing | 3.09e-03 | 13 | 117 | 2 | 533 | |
| Coexpression | GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | AQP9 ARHGAP4 PARP1 TSC22D1 ZNF608 WDR6 EPHA2 SLC26A11 TP53BP1 | 6.70e-06 | 200 | 170 | 9 | M309 |
| Coexpression | GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN | FOXO3 SP3 SCAF8 TRIM33 ZNF592 PHLPP1 HERC2 SLC26A11 SLC25A23 | 6.70e-06 | 200 | 170 | 9 | M9765 |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN | 6.70e-06 | 200 | 170 | 9 | M6554 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | COL4A6 ATP7B EP400 NUP98 PLXNB2 SLC1A5 ADCY9 ARHGAP4 AHNAK SLITRK5 | 1.38e-05 | 276 | 170 | 10 | M3063 |
| Coexpression | GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_DN | 4.58e-05 | 197 | 170 | 8 | M9721 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 5.09e-05 | 200 | 170 | 8 | M5851 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_DN | 5.09e-05 | 200 | 170 | 8 | M4027 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.56e-07 | 177 | 172 | 8 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.14e-06 | 200 | 172 | 8 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 6.31e-06 | 179 | 172 | 7 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.99e-06 | 189 | 172 | 7 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | facs-Pancreas|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.63e-06 | 191 | 172 | 7 | d48e5f67d384226add7d7fb2a124954136e09a82 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.63e-06 | 191 | 172 | 7 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-05 | 198 | 172 | 7 | 72d91bd0c727ecadc41e023a16c9326158db1b7b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-05 | 198 | 172 | 7 | 441608034c787e55691558a480dcd07e37419138 | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.22e-05 | 198 | 172 | 7 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | NS-critical-d_16-33-Epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.26e-05 | 199 | 172 | 7 | 3b68197ec01c5f2b315d9e9b6eb02d5f6b5b77a3 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.26e-05 | 199 | 172 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.50e-05 | 149 | 172 | 6 | a85a051e0d82430160967e72fa04b55f43e84513 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.59e-05 | 150 | 172 | 6 | 7a381f5ae94eba5eb60dcbf83416b4eb18c279ea | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.12e-05 | 155 | 172 | 6 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 3.23e-05 | 156 | 172 | 6 | b093dbba6662e4fffc8aa577587b77f64ac44b56 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.73e-05 | 160 | 172 | 6 | 529034a1101d7772d82f86beb5c6fa9c9dd97067 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 166 | 172 | 6 | 548d0d6c0ffd564036ddba78620734220ebb73d7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 166 | 172 | 6 | 80e164a89d22098cabe4a99a78283ba69ea0561e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 168 | 172 | 6 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.06e-05 | 169 | 172 | 6 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | 15-Airway-Epithelial-Club-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 5.23e-05 | 170 | 172 | 6 | 1418031cc4b4a87a48621eb53a3c819cd713ddd0 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 172 | 172 | 6 | b3c4adccc34bb9e4e78e40f4e2e23736c347cc75 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 172 | 172 | 6 | 2f1673fcb2356684d60871debb0f159aec553a1c | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.95e-05 | 174 | 172 | 6 | ab654e87c7eab7f33adc61be7a86da5c4d88008d | |
| ToppCell | BAL-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.95e-05 | 174 | 172 | 6 | d9bccff5258c4277bdd1edbd87e17c327ec125e8 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.95e-05 | 174 | 172 | 6 | 2453419842fd22d066631615403393bfe4449bb8 | |
| ToppCell | BAL-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.14e-05 | 175 | 172 | 6 | 6d5bdfbe53608e01c3845ecd908ca6d0fecc58f8 | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 6.14e-05 | 175 | 172 | 6 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.14e-05 | 175 | 172 | 6 | 6839ee3bb4457d13cb08ca8eb79ae33ddd256783 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.14e-05 | 175 | 172 | 6 | 9d6135e183179968555670abec39dff9da2c3219 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.54e-05 | 177 | 172 | 6 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.54e-05 | 177 | 172 | 6 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 6.54e-05 | 177 | 172 | 6 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.54e-05 | 177 | 172 | 6 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.54e-05 | 177 | 172 | 6 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 7.86e-05 | 183 | 172 | 6 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-05 | 184 | 172 | 6 | 3da93e7d8b62463e307cc0425c47dbd3bef66799 | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.10e-05 | 184 | 172 | 6 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.59e-05 | 186 | 172 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.59e-05 | 186 | 172 | 6 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.11e-05 | 188 | 172 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-05 | 188 | 172 | 6 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | facs-Pancreas-Endocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-05 | 189 | 172 | 6 | 010fdd70e9d0e21b856306a29ff877776a480319 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-05 | 189 | 172 | 6 | 1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-05 | 189 | 172 | 6 | 319e42f6e2322208de78bc666fb2c074707eb4da | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.66e-05 | 190 | 172 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | facs-Pancreas-Endocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 191 | 172 | 6 | b3de0393d6510543533cd851e47a0f95739a0e4e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.94e-05 | 191 | 172 | 6 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 9.94e-05 | 191 | 172 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 191 | 172 | 6 | 657297cd19d05a7e7bb74fc3a086fbd95f47aae4 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.02e-04 | 192 | 172 | 6 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | facs-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 193 | 172 | 6 | 15c86e20b97b6983410b36d308cddff56d141c98 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 198 | 172 | 6 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-04 | 198 | 172 | 6 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 198 | 172 | 6 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.21e-04 | 198 | 172 | 6 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Transverse-T_cell-Th1|T_cell / Region, Cell class and subclass | 1.24e-04 | 199 | 172 | 6 | 9271d9d36ffe1c169049d4340258f366916adfaf | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 199 | 172 | 6 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | 21-Trachea-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 1.24e-04 | 199 | 172 | 6 | 8eb8b086c38960200578a9fe8853ca6e894ddee4 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 199 | 172 | 6 | a8f4bd0e65f36b29535864fae4347369d5c864d2 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 199 | 172 | 6 | 667e1a56c33a2681af8dc1b7dbc3a9858e2c3c05 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 199 | 172 | 6 | 245b37df56dfbbdbac88f0e2fc3dfa0ed1abd588 | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.24e-04 | 199 | 172 | 6 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 199 | 172 | 6 | 2dae9db4d25f1a390134da2b6621564b274fe910 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 199 | 172 | 6 | eacea42e973f073b410f54c0a1b3a7f2dc2b5a29 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 199 | 172 | 6 | dbb33f0e151b150ba9ca4612973f8034c62e762b | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.28e-04 | 200 | 172 | 6 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-04 | 200 | 172 | 6 | 27f498bcd706d0751091662996795b5270e46f14 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.28e-04 | 200 | 172 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 1.28e-04 | 200 | 172 | 6 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.55e-04 | 70 | 172 | 4 | 986c7a1002a4ffd3a246495bedde2997ffdc2c9d | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.55e-04 | 70 | 172 | 4 | c0330216305491d7d57cdbea0ae3cb8e9092c8e3 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P3|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.55e-04 | 70 | 172 | 4 | 86dde790fcdaec2095e2256463953077811145d2 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.55e-04 | 70 | 172 | 4 | e604660b2efbc03e21806dcaecf7a72321673ae2 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_2|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.55e-04 | 131 | 172 | 5 | f2eee150f5cff852e8f52f09b35e26f17d80833b | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | RABEP2 POLM TSC22D2 ADGRA2 CREBBP RGS14 NECTIN2 SUGP1 NR3C2 ZC3H7B | 2.11e-06 | 199 | 166 | 10 | 3638_DN |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.21e-05 | 192 | 166 | 9 | 6013_DN | |
| Drug | colchicine; Down 200; 1uM; SKMEL5; HG-U133A | 1.37e-05 | 195 | 166 | 9 | 630_DN | |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.37e-05 | 195 | 166 | 9 | 953_DN | |
| Drug | DAPH; Up 200; 10uM; PC3; HG-U133A | 1.61e-05 | 199 | 166 | 9 | 578_UP | |
| Drug | butirosin A from Bacillus vitellinus; Down 200; 10uM; PC3; HG-U133A | 1.68e-05 | 200 | 166 | 9 | 666_DN | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 3.09e-06 | 6 | 160 | 3 | DOID:0050994 (implicated_via_orthology) | |
| Disease | dermoid cyst of ovary (implicated_via_orthology) | 2.92e-05 | 2 | 160 | 2 | DOID:5117 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 3.32e-05 | 12 | 160 | 3 | DOID:9119 (implicated_via_orthology) | |
| Disease | sick sinus syndrome (implicated_via_orthology) | 8.73e-05 | 3 | 160 | 2 | DOID:13884 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1A (implicated_via_orthology) | 1.74e-04 | 4 | 160 | 2 | DOID:0110425 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in medium HDL percentage | 2.46e-04 | 56 | 160 | 4 | EFO_0022333 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 2.46e-04 | 56 | 160 | 4 | EFO_0022251 | |
| Disease | Dyslipidemias | 2.91e-04 | 24 | 160 | 3 | C0242339 | |
| Disease | Dyslipoproteinemias | 2.91e-04 | 24 | 160 | 3 | C0598784 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 3.21e-04 | 60 | 160 | 4 | EFO_0021898 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 3.21e-04 | 60 | 160 | 4 | EFO_0022237 | |
| Disease | creatinine measurement | FOXO3 SCAF8 OGFR DACH1 TNRC6B PLXNB2 BIRC6 RGS14 PRDM8 SND1 ZNF592 AP5B1 NECTIN2 SLC23A1 OPLAH | 3.55e-04 | 995 | 160 | 15 | EFO_0004518 |
| Disease | obesity | 3.60e-04 | 241 | 160 | 7 | EFO_0001073 | |
| Disease | triglycerides in small HDL measurement | 3.64e-04 | 62 | 160 | 4 | EFO_0022158 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 3.64e-04 | 62 | 160 | 4 | EFO_0022339 | |
| Disease | Leukemia, Myelocytic, Acute | 3.75e-04 | 173 | 160 | 6 | C0023467 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 3.87e-04 | 63 | 160 | 4 | EFO_0022283 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 3.87e-04 | 63 | 160 | 4 | EFO_0022292 | |
| Disease | renal overload-type gout | 4.32e-04 | 6 | 160 | 2 | EFO_0021525 | |
| Disease | Acute Myeloid Leukemia, M1 | 6.12e-04 | 125 | 160 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 6.12e-04 | 125 | 160 | 5 | C1879321 | |
| Disease | serum urea measurement | 7.04e-04 | 195 | 160 | 6 | EFO_0009795 | |
| Disease | eosinophil cationic protein measurement | 8.01e-04 | 8 | 160 | 2 | EFO_0010913 | |
| Disease | common bile duct neoplasm (is_marker_for) | 8.01e-04 | 8 | 160 | 2 | DOID:4608 (is_marker_for) | |
| Disease | Acute erythroleukemia - M6a subtype | 8.01e-04 | 8 | 160 | 2 | C2930975 | |
| Disease | Acute myeloid leukemia FAB-M6 | 8.01e-04 | 8 | 160 | 2 | C2930976 | |
| Disease | Acute erythroleukemia - M6b subtype | 8.01e-04 | 8 | 160 | 2 | C2930977 | |
| Disease | Acute erythroleukemia | 8.01e-04 | 8 | 160 | 2 | C2930974 | |
| Disease | NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO | 8.01e-04 | 8 | 160 | 2 | C3891448 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 8.03e-04 | 200 | 160 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 8.69e-04 | 78 | 160 | 4 | EFO_0022187 | |
| Disease | longitudinal alcohol consumption measurement | 1.03e-03 | 9 | 160 | 2 | EFO_0007645 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 1.06e-03 | 37 | 160 | 3 | EFO_0022252 | |
| Disease | primary biliary cholangitis (is_implicated_in) | 1.28e-03 | 10 | 160 | 2 | DOID:12236 (is_implicated_in) | |
| Disease | intermediate density lipoprotein measurement | 1.31e-03 | 87 | 160 | 4 | EFO_0008595 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.44e-03 | 224 | 160 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | FOXO3 ARPP21 KIF26A HCN1 DACH1 NCAM1 BIRC6 SLC1A5 OTX1 SND1 TAF5 PRRC2B | 1.46e-03 | 801 | 160 | 12 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | serum gamma-glutamyl transferase measurement | FOXO3 SP3 ARPP21 POM121C POM121 SALL1 EPHA2 AHNAK NECTIN2 KMT2A ARHGEF2 TP53BP1 TJP3 | 1.49e-03 | 914 | 160 | 13 | EFO_0004532 |
| Disease | triglycerides in large LDL measurement | 1.65e-03 | 43 | 160 | 3 | EFO_0022319 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 1.74e-03 | 94 | 160 | 4 | EFO_0008595, EFO_0010351 | |
| Disease | concentration of large LDL particles measurement | 1.76e-03 | 44 | 160 | 3 | EFO_0022160 | |
| Disease | cholesterol in medium VLDL measurement | 1.76e-03 | 44 | 160 | 3 | EFO_0022225 | |
| Disease | saturated fatty acids measurement | 1.88e-03 | 45 | 160 | 3 | EFO_0022304 | |
| Disease | uric acid measurement | CNTN4 DACH1 BIRC6 ADCY9 KIAA0319 PRDM8 SUGP1 TBXT FOXK1 PRRC2B | 1.89e-03 | 610 | 160 | 10 | EFO_0004761 |
| Disease | Acute Promyelocytic Leukemia | 2.00e-03 | 46 | 160 | 3 | C0023487 | |
| Disease | Prostatic Neoplasms | 2.03e-03 | 616 | 160 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.03e-03 | 616 | 160 | 10 | C0376358 | |
| Disease | egg allergy measurement, parental genotype effect measurement | 2.19e-03 | 13 | 160 | 2 | EFO_0005939, EFO_0007018 | |
| Disease | schizophrenia, anorexia nervosa | 2.26e-03 | 48 | 160 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | risky sexual behaviour measurement | 2.33e-03 | 169 | 160 | 5 | EFO_0007877 | |
| Disease | cholesteryl ester 20:3 measurement | 2.40e-03 | 49 | 160 | 3 | EFO_0010347 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 2.40e-03 | 49 | 160 | 3 | EFO_0021897 | |
| Disease | cholesterol in medium LDL measurement | 2.40e-03 | 49 | 160 | 3 | EFO_0022224 | |
| Disease | C-reactive protein measurement | CARM1 ATXN2L SP3 ARPP21 SIGLEC9 APOB PRAG1 KANK2 ADCY9 SALL1 ZNF608 AHNAK NECTIN2 CEACAM20 TP53BP1 | 2.42e-03 | 1206 | 160 | 15 | EFO_0004458 |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.43e-03 | 103 | 160 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 2.54e-03 | 50 | 160 | 3 | EFO_0022334 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 2.54e-03 | 50 | 160 | 3 | EFO_0022247 | |
| Disease | ascorbic acid 3-sulfate measurement | 2.55e-03 | 14 | 160 | 2 | EFO_0800173 | |
| Disease | QT interval | 2.64e-03 | 534 | 160 | 9 | EFO_0004682 | |
| Disease | triglycerides to total lipids in large LDL percentage | 2.69e-03 | 51 | 160 | 3 | EFO_0022331 | |
| Disease | phospholipids in very small VLDL measurement | 2.69e-03 | 51 | 160 | 3 | EFO_0022300 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 2.69e-03 | 51 | 160 | 3 | EFO_0022302 | |
| Disease | total lipids in medium LDL | 2.85e-03 | 52 | 160 | 3 | EFO_0022180 | |
| Disease | serum alanine aminotransferase measurement | FOXO3 ATXN2L APOB TSC22D2 POM121C PLXNB2 PRAG1 EPHA2 AHNAK NECTIN2 SUGP1 TJP3 | 2.86e-03 | 869 | 160 | 12 | EFO_0004735 |
| Disease | sexual dimorphism measurement | FOXO3 ATXN2L SPATA31C2 APOB SPATA31C1 ADCY9 ZNF608 ZNF592 GLI2 ACAN AP5B1 NECTIN2 DOT1L TP53BP1 | 2.88e-03 | 1106 | 160 | 14 | EFO_0021796 |
| Disease | remnant cholesterol measurement | 2.88e-03 | 108 | 160 | 4 | EFO_0010815 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 2.90e-03 | 346 | 160 | 7 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | low density lipoprotein triglyceride measurement | 2.93e-03 | 15 | 160 | 2 | EFO_0009946 | |
| Disease | low density lipoprotein cholesterol measurement, response to selective serotonin reuptake inhibitor | 2.93e-03 | 15 | 160 | 2 | EFO_0004611, EFO_0005658 | |
| Disease | Hepatitis | 2.93e-03 | 15 | 160 | 2 | C0019158 | |
| Disease | triglycerides in HDL measurement | 3.00e-03 | 53 | 160 | 3 | EFO_0022317 | |
| Disease | grip strength measurement | 3.09e-03 | 350 | 160 | 7 | EFO_0006941 | |
| Disease | triglycerides in medium HDL measurement | 3.17e-03 | 54 | 160 | 3 | EFO_0022321 | |
| Disease | vitamin C measurement | 3.34e-03 | 16 | 160 | 2 | EFO_0600003 | |
| Disease | amygdala volume change measurement | 3.34e-03 | 16 | 160 | 2 | EFO_0021490 | |
| Disease | free cholesterol measurement | 3.39e-03 | 113 | 160 | 4 | EFO_0008591 | |
| Disease | physical activity measurement, body mass index | 3.50e-03 | 114 | 160 | 4 | EFO_0004340, EFO_0008002 | |
| Disease | triglycerides in LDL measurement | 3.51e-03 | 56 | 160 | 3 | EFO_0022320 | |
| Disease | triglycerides in very large VLDL measurement | 3.51e-03 | 56 | 160 | 3 | EFO_0022325 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 3.51e-03 | 56 | 160 | 3 | EFO_0022316 | |
| Disease | HMG CoA reductase inhibitor use measurement | 3.77e-03 | 189 | 160 | 5 | EFO_0009932 | |
| Disease | triglycerides in IDL measurement | 3.88e-03 | 58 | 160 | 3 | EFO_0022149 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.05e-03 | 276 | 160 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | triglycerides in VLDL measurement | 4.07e-03 | 59 | 160 | 3 | EFO_0022326 | |
| Disease | triglycerides to total lipids in small LDL percentage | 4.07e-03 | 59 | 160 | 3 | EFO_0022337 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 4.07e-03 | 59 | 160 | 3 | EFO_0022260 | |
| Disease | glycoprotein measurement | 4.08e-03 | 119 | 160 | 4 | EFO_0004555 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 4.22e-03 | 18 | 160 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | phospholipids in small VLDL measurement | 4.27e-03 | 60 | 160 | 3 | EFO_0022146 | |
| Disease | cholesterol to total lipids in IDL percentage | 4.27e-03 | 60 | 160 | 3 | EFO_0022233 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 4.33e-03 | 121 | 160 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | triglycerides in small VLDL measurement | 4.47e-03 | 61 | 160 | 3 | EFO_0022145 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 4.47e-03 | 61 | 160 | 3 | C1961102 | |
| Disease | free cholesterol in very large VLDL measurement | 4.47e-03 | 61 | 160 | 3 | EFO_0022274 | |
| Disease | free cholesterol in VLDL measurement | 4.47e-03 | 61 | 160 | 3 | EFO_0022276 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.47e-03 | 61 | 160 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | triglycerides in medium LDL measurement | 4.68e-03 | 62 | 160 | 3 | EFO_0022322 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 4.68e-03 | 62 | 160 | 3 | EFO_0022306 | |
| Disease | total lipids in very large VLDL measurement | 4.68e-03 | 62 | 160 | 3 | EFO_0022313 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 4.68e-03 | 62 | 160 | 3 | EFO_0022263 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ATGVTVPGLGTGTAA | 566 | Q5DID0 | |
| GGVSGGHINPAVSLA | 76 | O43315 | |
| PAITTGGSAAVLAGT | 2601 | Q96L91 | |
| TNPFLSLSGAEGSGG | 1061 | P55198 | |
| ATASSVGAAGIPAGG | 421 | Q15758 | |
| LGGSGGLPTNETTFA | 86 | Q5FYA8 | |
| TGPQGFTGSTGLSGL | 61 | Q14031 | |
| SSFGVTPAVGGLSSG | 1586 | Q9NR09 | |
| TPAVGGLSSGTVGEA | 1591 | Q9NR09 | |
| GFIQGSSGTILSPGF | 926 | Q7Z408 | |
| GAGGSGVASPTITVA | 621 | P46379 | |
| TPVIFAGTSGCGVGN | 676 | Q96PE1 | |
| GGLDGLGPSSQVATS | 46 | P35670 | |
| SGGNTSPGVTANGEA | 691 | Q92974 | |
| VGPQSSSLSSGAIAG | 436 | Q6UY09 | |
| VVSGGGSFSSSQPIG | 81 | A6NHX0 | |
| VGGQGSSLSIFAGPA | 261 | A6NJG6 | |
| GGSGSSINPGIGNVS | 76 | Q92793 | |
| VTPANVSGGGGSKSE | 701 | Q8IWV2 | |
| GVDASAPQIGGSITG | 396 | Q09666 | |
| GSVAISGALAGSPAS | 941 | Q8TEK3 | |
| GISAGGGVASSTPIN | 121 | Q9UI36 | |
| NLPSTGGSLSVAAGG | 181 | O43633 | |
| STGQQLPTGGFSGSG | 596 | Q9UBL0 | |
| PGAAAIGSARGQSTG | 91 | Q8WWM7 | |
| VGQALPGATVTLTGG | 306 | Q9NP87 | |
| APGTTVTTSGAGAAA | 6 | Q13434 | |
| TPDGGVVLISGTGSN | 116 | Q9UJ70 | |
| AGPSSVVSLQERGGG | 191 | Q6ZS82 | |
| GGVGSSSSLPQSRQG | 241 | Q9H5N1 | |
| GVDVPLGTGISSGVN | 966 | P09874 | |
| TVSAGTPFEGLQGSG | 11 | Q9ULE6 | |
| LTPGALTAAAAGTGT | 51 | P55042 | |
| LASAGSAEGVGGAPT | 211 | Q9P2A4 | |
| CGGNLTGLQGTFSTP | 301 | Q9BY79 | |
| PSTASGGGQLNRAGS | 166 | Q9P260 | |
| SLDGGSNVGGTPSTL | 2436 | Q8WXI7 | |
| SGDQGITSLTNPSGG | 3466 | Q8WXI7 | |
| GALTLANSVVSTPGG | 736 | Q99102 | |
| GGLSGFPSDSQLGTA | 111 | Q9BQK8 | |
| VTQASQPGGLFGTAT | 321 | P52948 | |
| QPGGLFGTATNTSTG | 326 | P52948 | |
| SGSGAQVGGPISSGS | 601 | P02545 | |
| ASIPSSAIVGVNSGG | 506 | P08235 | |
| SIGTVFQSSSPGGGG | 741 | Q8TD19 | |
| TVGGAQASGTLIGVG | 401 | Q8NBP5 | |
| SATSAGTVGEQGRPG | 396 | Q5T442 | |
| SLTGASGNASSLPGV | 2481 | O95714 | |
| AALLGGGQVSGDTSP | 551 | Q13387 | |
| STGIVQGSSGAQGSG | 556 | Q86X55 | |
| VATVGLVSSTGPGGD | 151 | O15031 | |
| GVSAGSITASPGASA | 1786 | Q7Z5P9 | |
| KPSVGRTGTTGQSGA | 2311 | Q7Z5P9 | |
| AGVTGTNGPSSAGVT | 3231 | Q7Z5P9 | |
| TNGPSSAGVTGITGS | 3236 | Q7Z5P9 | |
| AEVTGTTGPLAGVTG | 3311 | Q7Z5P9 | |
| EATGLPGVSAGVTGT | 3731 | Q7Z5P9 | |
| PGVSAGVTGTTGSLA | 3736 | Q7Z5P9 | |
| AGLSAGVTGITGPSA | 3786 | Q7Z5P9 | |
| TGPSAGVTGSTGLLA | 3876 | Q7Z5P9 | |
| GLSAGVTGITGPSAG | 3966 | Q7Z5P9 | |
| PSAGITGTNGLSAEV | 4136 | Q7Z5P9 | |
| PLAGGTGTTGLSAGV | 4156 | Q7Z5P9 | |
| SSTGVTGATGPLAGV | 4356 | Q7Z5P9 | |
| TGATGPLAGVTGTTG | 4361 | Q7Z5P9 | |
| GINGLSAGVTGTTGP | 4501 | Q7Z5P9 | |
| GTNGLSAEVTGTTGP | 4561 | Q7Z5P9 | |
| GLPGVSAGVTGTIGS | 4581 | Q7Z5P9 | |
| SAGVTGTIGSPAAVT | 4586 | Q7Z5P9 | |
| GTNGLSAEATGTTGP | 4651 | Q7Z5P9 | |
| GTTGPSAGITGTNGL | 4711 | Q7Z5P9 | |
| GTNGLSAEVTGTTGP | 4721 | Q7Z5P9 | |
| GTTGPLAGVTGTIGL | 4731 | Q7Z5P9 | |
| GINGLSAGVTGTTGP | 4781 | Q7Z5P9 | |
| GLPGVSAGVTGTIGS | 4841 | Q7Z5P9 | |
| SAGVTGTIGSPAAVT | 4846 | Q7Z5P9 | |
| SAGVTGTTGPSAGIA | 4926 | Q7Z5P9 | |
| GTTGPSAGIAGTNGL | 4931 | Q7Z5P9 | |
| GTNGLSAEVTGTAGP | 5051 | Q7Z5P9 | |
| GTAGPLAGVTGTTGL | 5061 | Q7Z5P9 | |
| SAGVTGTTGPSAGIA | 5306 | Q7Z5P9 | |
| GTTGPSAGIAGTNGL | 5311 | Q7Z5P9 | |
| SAEATGLPGVSAGVT | 5496 | Q7Z5P9 | |
| GLPGVSAGVTGTIGS | 5501 | Q7Z5P9 | |
| SAGVTGTIGSPAGVT | 5506 | Q7Z5P9 | |
| GTIGSPAGVTGTARL | 5511 | Q7Z5P9 | |
| SAGVTGITGPSAGVT | 5696 | Q7Z5P9 | |
| TTGPSAGITGTNGLS | 5901 | Q7Z5P9 | |
| GITSAPGKQAGTSGV | 7226 | Q7Z5P9 | |
| TGAEIKSGATSGVPG | 7441 | Q7Z5P9 | |
| NPGSEIGTTGIVSGT | 7936 | Q7Z5P9 | |
| GVSSFTIQSILGGGP | 16 | A2RU54 | |
| STATSAGAGQGPAGA | 6 | Q8TAD7 | |
| VTPGGSAARAGLQVG | 496 | Q86UT5 | |
| VGSLSGAEGVPVSSQ | 456 | P56270 | |
| QKPTGTFSSGGGSVA | 1941 | P35658 | |
| SVAPAGLGGALSTVT | 206 | Q9ULI4 | |
| LPGSGSILENFSGSG | 761 | P10070 | |
| RSAPSGQNGVGSLSG | 11 | Q8IVH2 | |
| TTALAAGGALGPTSG | 101 | Q2VPB7 | |
| TGGSTAQPSGFNIGS | 161 | P37198 | |
| VANIGTQTTGPSGVG | 481 | Q4VXU2 | |
| GETVPGGQAQTGAST | 396 | Q9UBG3 | |
| LVAGASGGASPVGFT | 1006 | Q9Y3Q4 | |
| GLGGNPVAAASSLST | 156 | P32242 | |
| SGTLGSGQAPETSGL | 1611 | P16112 | |
| GVTELSGLSSGQPGI | 1751 | P16112 | |
| SGLSSGQPGISGEAS | 1756 | P16112 | |
| LTPGAGSAGGTVSEL | 566 | Q9Y5I0 | |
| GSAAPAGSGSFGINV | 1081 | A8CG34 | |
| AGSGSFGINVATPGS | 1086 | A8CG34 | |
| TPFTGGLGQNALGTT | 1121 | A8CG34 | |
| GSAAPAGSGSFGINV | 686 | A6NF01 | |
| AGSGSFGINVATPGS | 691 | A6NF01 | |
| GSAAPAGSGSFGINV | 1101 | Q96HA1 | |
| AGSGSFGINVATPGS | 1106 | Q96HA1 | |
| GTGAGISPVILNSGE | 141 | Q8IZD4 | |
| GPATAAGGLSGGTQA | 196 | A0A2Z4LIS9 | |
| GISTSAASPAVGTVG | 3996 | P04114 | |
| EAGFGGGPNATITTS | 386 | P07199 | |
| AVPGTGLQAGGRSTV | 821 | O60741 | |
| LSGTVGVAAVTAGPG | 111 | A1L0T0 | |
| LPGLQLTAGTASGVG | 116 | Q7Z5L3 | |
| QPSGGSLGCVAVGSS | 1236 | Q9Y6R7 | |
| LPGGTQVLDGTSGFS | 316 | Q96S94 | |
| TLSPEGSGNLAVIGG | 526 | P29317 | |
| SGAVTTPAGVIAAAG | 711 | P85037 | |
| GSQVSSGPRGQGTAS | 596 | O60503 | |
| SGPRGQGTASSGNVS | 601 | O60503 | |
| GGSVQAGPVSSGLAL | 646 | Q2TAC2 | |
| DVTLGNSSAPSGGGA | 421 | Q96P31 | |
| GNRNPGSSGTGGTAT | 306 | P02671 | |
| SAAGSTASLVGVGLP | 151 | Q63ZY3 | |
| LLPQSVGGTAATAAG | 3301 | Q03164 | |
| GASGRNVTTGSLGEP | 31 | Q9H078 | |
| GVASDSGGGVSPALA | 506 | Q9NZ56 | |
| TGILKGNGSPVNGSS | 316 | Q96EE3 | |
| ASIGGTATLTGTGPN | 216 | Q86YT5 | |
| GFGSLVIPGGSVASN | 731 | Q9UPN6 | |
| SLGSGNSSPVSGLTG | 1266 | Q9NSC2 | |
| ATSASIGAAGVPQAG | 401 | P43005 | |
| APGGGAFTTLNGSLT | 366 | Q06587 | |
| GTGASSNPSVGLNFG | 31 | Q9BVL2 | |
| SGTSGAAAAGPNTTG | 86 | P0DMQ5 | |
| VASGGAQTLALAGSP | 471 | Q9NZT2 | |
| GPATAAGGLSGGTQA | 111 | O43524 | |
| AAGPASGTGSSQEGL | 16 | Q8NBR6 | |
| ATVVSGSASGPAAPG | 171 | Q15542 | |
| NSSGGAGTVGRGLVS | 201 | Q9NRF2 | |
| PAASVGTGVAGGAVS | 81 | Q9UPN9 | |
| GTGVAGGAVSTPAPA | 86 | Q9UPN9 | |
| PGANGSSVSQVSGGS | 226 | Q9HCJ0 | |
| AVAGSAPLSQGSSGI | 371 | Q8WUY3 | |
| LAASVPGISGLGGSN | 266 | B4DYI2 | |
| PGISGLGGSNSQVSA | 271 | B4DYI2 | |
| PANGGGVVSARSVSG | 101 | O75157 | |
| LVGPVGGAAAQASSG | 426 | Q9UMZ2 | |
| PGGAGTTPQGTATAA | 266 | Q15270 | |
| VASVPAISGLGGSNS | 261 | Q5VVP1 | |
| SGSSAVLSGPAGGVV | 281 | O14841 | |
| GGGAAEGPSAQSTIS | 171 | Q8N2H9 | |
| TSVPQLGSAGSTSGG | 461 | Q9NQV8 | |
| VASVPAISGLGGSNS | 261 | Q8IWB4 | |
| AGVSSGAGSGPVVNA | 11 | Q8ND83 | |
| ATSGVTQGVVGGAGA | 341 | Q9Y336 | |
| QSGGSSGGPAVPTVQ | 6 | Q7KZF4 | |
| STVSGGGGPQESQTL | 6 | Q8TC41 | |
| GGGPQESQTLASGTA | 11 | Q8TC41 | |
| AAGVSVGPGVTSGVN | 346 | Q15714 | |
| SAGSVQRVPSGAAGG | 1276 | Q14160 | |
| VSNGGDSGILSSPSG | 306 | Q9P2P6 | |
| LVNFSEGGPGSNSTG | 311 | P61371 | |
| VIVGAPGEGNSTGSL | 56 | P20701 | |
| VPAISGLGGSNSQVS | 276 | P0DKV0 | |
| SQGPSQSGGTGELDL | 81 | P08047 | |
| VGAGLQTAGESGSSP | 811 | P98171 | |
| ANGSPTSGLSTGAIV | 711 | P13591 | |
| PVNKGTTTVDGAGFG | 591 | Q8IWZ8 | |
| VASVPAISGLGGSNS | 261 | Q5VYP0 | |
| VIGSTSAPGQGGILA | 121 | P43308 | |
| GTGSGTQGATKPLST | 1191 | Q6ZU65 | |
| IPGGRASVGATSGLV | 281 | Q9Y330 | |
| TVIGEPTAGGALSVG | 866 | P10745 | |
| VASVPAISGLGGSNS | 261 | Q5TZJ5 | |
| GNGSTSSSPNIGVLG | 376 | Q9UHI7 | |
| VASVPAISGLGGSNS | 261 | Q5VU36 | |
| SLGAGGGASSVPLSV | 651 | O94991 | |
| GSPSTSAGFGGALNT | 1051 | Q12816 | |
| AQSGVCTPAGGLVTG | 371 | Q86WA9 | |
| TASTGLINVAGAGTP | 271 | Q9NXZ1 | |
| SSVGAAGVPAGGVLT | 416 | P43007 | |
| TLGQVAAGGAFTSTP | 496 | Q02447 | |
| GVGDAPGTSNGATVS | 1101 | Q92610 | |
| GCPGGTTSSVIGVGA | 371 | P29144 | |
| GIQPPSSVGASSGVN | 1881 | Q5JSZ5 | |
| VVAAAVPSSGSGVGG | 11 | O94826 | |
| GAVTPGSQAAAVSNG | 356 | O15178 | |
| STTGPQGQGEGRGSS | 26 | O43566 | |
| EVSPSQTGGSSGDLG | 1286 | Q12888 | |
| SLPAANGLSSGVGGG | 431 | P49790 | |
| PVVGSGSSGGGNAFT | 541 | Q9NNW5 | |
| PTDGSSGQNSKVGTG | 676 | Q86YV5 | |
| AAGPGASSVAGVVGV | 16 | Q9H832 | |
| TTVSGGNGSVFQAGP | 546 | A8K0R7 | |
| RAVGVGPGSSAGSNA | 556 | O95049 | |
| LLGPGVGQGDSATAS | 1111 | Q8N398 | |
| NSTSGGLFGVVPGGT | 71 | Q6ZMS4 | |
| SALGQSVSSGGSGNP | 151 | Q9ULD9 | |
| GGLQSTPGRSGVTAE | 446 | O60346 | |
| AGAVAGAVSRTGTAP | 191 | Q9BV35 | |
| ISQLEGGSELGGSSP | 21 | P17027 | |
| GVTAPVGSSGGSDLL | 71 | Q96C55 | |
| GGTSVPTAGEAVRGL | 581 | Q53EQ6 | |
| DASSQTQGAGGPAGV | 36 | Q9BT76 | |
| SVVGEATGGPTRNGA | 16 | Q9NQZ8 | |
| GQSNSLPTAGSVGGG | 576 | Q9UPU9 | |
| SVGTIQGAGPISGPS | 111 | Q3YBR2 | |
| AGVPSGSGGTVAPAT | 171 | O15209 | |
| VGGTSVGSLGVPGSV | 456 | O15209 | |
| GAGSSPVSGGVNLFA | 46 | Q9BQ61 | |
| TSQIASAGVPGPGGS | 416 | Q8NBT3 | |
| GAARGPSGTDTVSGQ | 426 | Q9UPQ9 | |
| PASLQLGTGAGAAGS | 91 | Q9GZV5 | |
| SLSLVQGGLSGSGVP | 271 | Q9UGR2 | |
| GLLPGSEGAFNSSVG | 186 | Q5VV43 | |
| VAAAGGVVSGPSTSE | 246 | Q96RE7 | |
| VRETPNTAGAGATGG | 346 | Q92692 |